J.Molner AS (OTSE:MOLNR) Net Margin % : -184.73% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. J.Molner AS's Net Income for the six months ended in Dec. 2023 was €-0.64 Mil. J.Molner AS's Revenue for the six months ended in Dec. 2023 was €0.35 Mil. Therefore, J.Molner AS's net margin for the quarter that ended in Dec. 2023 was -184.73%.

The historical rank and industry rank for J.Molner AS's Net Margin % or its related term are showing as below:

OTSE:MOLNR' s Net Margin % Range Over the Past 10 Years
Min: -322.92 Med: -175.57 Max: -64.95
Current: -175.73

OTSE:MOLNR's Net Margin % is ranked worse than
88.32% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.53 vs OTSE:MOLNR: -175.73

J.Molner AS Net Margin % Historical Data

The historical data trend for J.Molner AS's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Net Margin % Chart

J.Molner AS Annual Data

Trend

Dec21

Dec22

Dec23

Net Margin %

-64.95

-322.92

-175.57

J.Molner AS Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	-	-151.22	-1,328.57	-164.21	-184.73

Competitive Comparison of J.Molner AS's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J.Molner AS's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's Net Margin % distribution charts can be found below:

* The bar in red indicates where J.Molner AS's Net Margin % falls into.

J.Molner AS Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

J.Molner AS's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.085	/	0.618
	=	-175.57 %

J.Molner AS's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.641	/	0.347
	=	-184.73 %

J.Molner AS (OTSE:MOLNR) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

J.Molner AS Net Margin % Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

J.Molner AS (OTSE:MOLNR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Net Margin %

Traded in Other Exchanges

N/A

Address

Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618

Website

https://www.jmolner.com

J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines